MIR222HG Attenuates Macrophage M2 Polarization and Allergic Inflammation in Allergic Rhinitis by Targeting the MiR146a-5p/TRAF6/NF-κB Axis
Overview
Affiliations
Although M2 macrophages are involved in the orchestration of type 2 inflammation in allergic diseases, the mechanisms underlying non-coding RNA (ncRNA)-mediated macrophage polarization in allergic rhinitis (AR) have not been systematically understood. Here, we identified long non-coding RNA (lncRNA) MIR222HG as a key regulator of macrophage polarization and revealed its role in AR. Consistent with our bioinformatic analysis of GSE165934 dataset derived from the Gene Expression Omnibus (GEO) database, lncRNA-MIR222HG and murine mir222hg were downregulated in our clinical samples and animal models of AR, respectively. Mir222hg was upregulated in M1 macrophages and downregulated in M2 macrophages. The allergen-ovalbumin facilitated polarization of RAW264.7 cells to the M2 phenotype, accompanied by the downregulation of mir222hg expression in a dose-dependent manner. Mir222hg facilitates macrophage M1 polarization and reverses M2 polarization caused by ovalbumin. Furthermore, mir222hg attenuates macrophage M2 polarization and allergic inflammation in the AR mouse model. Mechanistically, a series of gain- and loss-of-function experiments and rescue experiments were performed to verify the role of mir222hg as a ceRNA sponge that adsorbed miR146a-5p, upregulated Traf6, and activated the IKK/IκB/P65 pathway. Collectively, the data highlight the remarkable role of MIR222HG in the modulation of macrophage polarization and allergic inflammation, as well as its potential role as a novel AR biomarker or therapeutic target.
Li B, Dong B, Xie L, Li Y Int J Gen Med. 2025; 18:529-565.
PMID: 39911299 PMC: 11796455. DOI: 10.2147/IJGM.S493021.
The role of natural products targeting macrophage polarization in sepsis-induced lung injury.
Li Y, Ai S, Li Y, Ye W, Li R, Xu X Chin Med. 2025; 20(1):19.
PMID: 39910395 PMC: 11800549. DOI: 10.1186/s13020-025-01067-4.
Vitamin D and allergic diseases.
Zhang P, Xu Q, Zhu R Front Immunol. 2024; 15:1420883.
PMID: 39026686 PMC: 11254667. DOI: 10.3389/fimmu.2024.1420883.
Advanced Immunomodulatory Biomaterials for Therapeutic Applications.
Park J, Kim D Adv Healthc Mater. 2024; 14(5):e2304496.
PMID: 38716543 PMC: 11834384. DOI: 10.1002/adhm.202304496.
Macrophage polarization: an important role in inflammatory diseases.
Luo M, Zhao F, Cheng H, Su M, Wang Y Front Immunol. 2024; 15:1352946.
PMID: 38660308 PMC: 11039887. DOI: 10.3389/fimmu.2024.1352946.